???pagination.result.count???
???pagination.result.page???
1
Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes. , Richter K ., Front Immunol. January 1, 2023; 14 1140592.
Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation. , Calzaferri F., J Med Chem. February 25, 2021; 64 (4): 2272-2290.
Comparative Embryonic Spatio-Temporal Expression Profile Map of the Xenopus P2X Receptor Family. , Blanchard C., Front Cell Neurosci. January 1, 2019; 13 340.
Purinergic receptor-mediated Ca signaling in the olfactory bulb and the neurogenic area of the lateral ventricles. , Hassenklöver T ., Purinergic Signal. December 1, 2010; 6 (4): 429-45.
A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages. , Shemon AN., J Biol Chem. January 27, 2006; 281 (4): 2079-86.
An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. , Gu BJ., J Biol Chem. July 23, 2004; 279 (30): 31287-95.